Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Inv. presentation
Appointed director
Diadexus, Inc. (DDXS) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/28/2016 8-K Quarterly results
03/28/2016 8-K Quarterly results
Docs: "Press Release entitled “Updated - Diadexus, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results.”"
10/26/2015 8-K Quarterly results
Docs: "PLAC ® ELISA o Signed an exclusive, license and supply agreement granting OriGene rights to develop and commercialize Diadexus' proprietary PLAC ® ELISA in certain Asian countries . Diadexus will supply to OriGene the raw materials and reagents necessary to assemble, develop, produce, seek marketing authorization for, and sell PLAC ® ELISA in the Territory. Upon commencement of commercial sales, Diadexus is eligible to receive sales-based milestones as well as mid-single-digit royalties on net sales. 3 ● PLAC ® Activity o A new partnership established with Mayo Clinic for the integration and use of PLAC ® Activity testing into clinical practice. The parties recently completed a successful kick-off meeting with key sales and marketing personnel. Once fully integrated, the test will be..."
08/13/2015 8-K Quarterly results
Docs: "Diadexus, Inc. Reports Second Quarter 2015 Financial Results",
"Diadexus, Inc. Reports Second Quarter 2015 Financial Results"
05/12/2015 8-K Quarterly results
Docs: "Diadexus, Inc. Reports First Quarter 2015 Financial Results"
03/12/2015 8-K Quarterly results
Docs: "Diadexus, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results"
11/05/2014 8-K Quarterly results
Docs: "--"
07/28/2014 8-K Quarterly results
Docs: "diaDexus, Inc. Reports Second Quarter 2014 Financial Results 23 Percent Year-Over-Year Revenue Growth Conference Call Today at 4:30 p.m. ET"
05/07/2014 8-K Quarterly results
Docs: "diaDexus, Inc. Reports First Quarter 2014 Financial Results"
03/05/2014 8-K Quarterly results
Docs: "diaDexus, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results"
10/29/2013 8-K Form 8-K - Current report
08/08/2013 8-K Form 8-K - Current report
05/06/2013 8-K Form 8-K - Current report
03/07/2013 8-K Form 8-K - Current report
11/07/2012 8-K Form 8-K - Current report
08/07/2012 8-K Form 8-K - Current report
05/08/2012 8-K Form 8-K - Current report
11/09/2011 8-K Form 8-K - Current report
08/15/2011 8-K Form 8-K - Current report
05/16/2011 8-K Form 8-K - Current report
11/15/2010 8-K Quarterly results
Docs: "diaDexus, Inc. Reports 2010 Third Quarter Financial Results Guidance for Year-End 2010 and 2011 Outlook South San Francisco, CA – November 15, 2010 – diaDexus, Inc. , a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced financial results for the third quarter of 2010. Total revenues for the 2010 third quarter at $3.2 million represented a 26% growth over total revenues of $2.5 million for the third quarter of 2009. Net cash used in operating activities for the third quarter of 2010 was $2.2 million. Year-to-date revenues for the period ended September 30, 2010 were $8.5 million vs. $8.8 million in the same period a year ago, a decrease primarily attributable ..."
03/07/2008 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy